title: Evaluation of a new selective medium, BD BBL CHROMagar MRSA II, for detection of methicillin-resistant Staphylococcus aureus in different specimens.
abstract: The sensitivity of screening for methicillin-resistant Staphylococcus aureus (MRSA) can be improved by adding other specimen sites to nares. We describe an evaluation of a new selective medium, BBL CHROMagar MRSA II (CMRSAII), for its ability to detect MRSA from different specimen types. CMRSAII is a chromogenic medium which incorporates cefoxitin for the detection of MRSA. A study was performed at four clinical laboratories with the following specimens: 1,446 respiratory, 694 stool, 1,275 skin, and 948 wound specimens and 688 blood culture bottles containing Gram-positive cocci. The recovery of MRSA on traditional culture media was compared to results with CMRSAII. S. aureus was tested by cefoxitin disk diffusion. CMRSAII was interpreted as positive for MRSA at 24 h (range, 18 to 28 h) based solely on the visualization of mauve-colored colonies and at 48 h (range, 36 to 52 h) based on detection of mauve colonies with subsequent confirmation as S. aureus (by coagulase or latex agglutination testing). MRSA was recovered more frequently on CMRSAII (89.8% at 24 h and 95.6% at 48 h) than on traditional culture plates (83.1% at 24 h and 79.8% at 48 h) for all specimen types combined (P < 0.001). The percent sensitivities of CMRSAII at 24- and 48-h reads, respectively, were 85.5 and 92.4% for respiratory specimens, 87.9% and 98.3% for stool specimens, 88.4% and 96.1% for skin specimens, 92.1% and 94.6% for wound specimens, and 100% and 100% for positive blood cultures. The specificity was 99.8% for respiratory specimens and 100% for all others. In conclusion, CMRSAII is a reliable screening medium for multiple specimen types.
authors.affiliation: Hygiene-Institut, University of Heidelberg, INF 324, 69 120 Heidelberg, Germany. Constanze.Wendt@labor-limbach.de
authors.forename: C
authors.initials: C
authors.lastname: Wendt
authors.forename: N L
authors.initials: NL
authors.lastname: Havill
authors.forename: K C
authors.initials: KC
authors.lastname: Chapin
authors.forename: J M
authors.initials: JM
authors.lastname: Boyce
authors.forename: R
authors.initials: R
authors.lastname: Dickenson
authors.forename: U
authors.initials: U
authors.lastname: Eigner
authors.forename: S
authors.initials: S
authors.lastname: Schütt
authors.forename: A M
authors.initials: AM
authors.lastname: Fahr
mesh_terms: D001431:Bacteriological Techniques / Q000379:methods*; D001769:Blood / Q000382:microbiology; D003470:Culture Media / Q000737:chemistry*; D005243:Feces / Q000382:microbiology; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification*; D012137:Respiratory System / Q000382:microbiology; D012680:Sensitivity and Specificity; D012867:Skin / Q000382:microbiology; D013203:Staphylococcal Infections / Q000175:diagnosis*; D014947:Wounds and Injuries / Q000382:microbiology
chemical_list: D003470:Culture Media
references.citation: J Clin Microbiol. 2005 Nov;43(11):5536-40
references.pmid: 16272482
references.citation: Diagn Microbiol Infect Dis. 2007 Nov;59(3):319-23
references.pmid: 17913436
references.citation: Infect Control Hosp Epidemiol. 2008 Oct;29 Suppl 1:S62-80
references.pmid: 18840090
references.citation: J Hosp Infect. 2009 Apr;71(4):373-4
references.pmid: 19215999
references.citation: J Med Microbiol. 2007 Apr;56(Pt 4):491-494
references.pmid: 17374889
references.citation: J Clin Microbiol. 2004 Oct;42(10):4519-23
references.pmid: 15472303
references.citation: J Clin Microbiol. 2006 Dec;44(12):4561-3
references.pmid: 17050808
references.citation: J Clin Microbiol. 2007 Aug;45(8):2486-90
references.pmid: 17537949
references.citation: J Clin Microbiol. 2006 Jul;44(7):2575-6
references.pmid: 16825383
references.citation: J Clin Microbiol. 2009 Mar;47(3):566-8
references.pmid: 19144795
references.citation: J Clin Microbiol. 2008 May;46(5):1577-87
references.pmid: 18322065
references.citation: J Clin Microbiol. 2006 Feb;44(2):637-9
references.pmid: 16455933
references.citation: J Hosp Infect. 2002 Jul;51(3):189-200
references.pmid: 12144798
references.citation: Eur J Clin Microbiol Infect Dis. 2009 Jan;28(1):47-53
references.pmid: 18663499
references.citation: Am J Infect Control. 2007 Mar;35(2):73-85
references.pmid: 17327185
references.citation: J Hosp Infect. 2008 Aug;69(4):315-20
references.pmid: 18602183
references.citation: J Hosp Infect. 2006 May;63 Suppl 1:S1-44
references.pmid: 16581155
references.citation: J Clin Pathol. 2008 Jul;61(7):841-3
references.pmid: 18413653
references.citation: Clin Microbiol Infect. 2006 Dec;12(12):1168-74
references.pmid: 17121622
references.citation: Euro Surveill. 2008 Nov 13;13(46):
references.pmid: 19021951
references.citation: Intensive Care Med. 2008 Sep;34(9):1703-6
references.pmid: 18500421
references.citation: J Med Microbiol. 2007 Apr;56(Pt 4):500-503
references.pmid: 17374891
references.citation: Eur J Clin Microbiol Infect Dis. 2009 Apr;28(4):363-9
references.pmid: 18855028
references.citation: J Clin Microbiol. 2007 Jan;45(1):154-8
references.pmid: 17093032
references.citation: J Hosp Infect. 2008 Dec;70(4):388-9
references.pmid: 18977554
references.citation: J Med Microbiol. 2007 Jan;56(Pt 1):43-46
references.pmid: 17172515
references.citation: J Clin Microbiol. 2008 Apr;46(4):1174-7
references.pmid: 18234863